CBCharles BoucherMD, PhDSlidesetHIVBrazilian HIV Clinical Forum 2018Resistance Characteristics of Integrase Inhibitors- Charles Boucher, MD, PhDView Slideset
DBDavid BackPhDSlidesetHIVBrazilian HIV Clinical Forum 2018Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors- David Back, PhDView Slideset
SlidesetHIVBrazilian HIV Clinical Forum 2018The Integrase Inhibitors drug class: a comparative clinical review- Ian FrankView Slideset
SlidesetHIVBrazilian HIV Clinical Forum 2018Transitioning to use of Integrase Inhibitors in Brazil- Estevão NunesView Slideset
CHChien-Ching HungMD, PhDSlidesetHIVAsia-Pacific HIV Clinical Forum 2018Reduced Drug Regimens- Chien-Ching Hung, MD, PhDView Slideset
MBMark BoydBA, BM, BS, DCTH&H, MHID, MD, FRACPSlidesetHIVAsia-Pacific HIV Clinical Forum 2018The role of InSTIs in International Treatment Guidelines- Mark Boyd, BA, BM, BS, DCTH&H, MHID, MD, FRACPView Slideset
SKSaye KhooMD, PhDSlidesetHIVAsia-Pacific HIV Clinical Forum 2018Novel Delivery Systems- Saye Khoo, MD, PhDView Slideset
GCLGrace Chung-Yan LuiMBChB (Hons), FHKCP, FHKAMSlidesetHIVAsia-Pacific HIV Clinical Forum 2018Clinical Case - InSTIs use in Hong Kong- Grace Chung-Yan Lui, MBChB (Hons), FHKCP, FHKAMView Slideset
SlidesetHIVAsia-Pacific HIV Clinical Forum 2018Role of Integrase Inhibitors in the clinical care of HIV infected pregnant women and adolescents- Thanyawee Puthanakit, MDView Slideset
KBKees BrinkmanMD, PhDSlidesetHIVAsia-Pacific HIV Clinical Forum 2018Optimal use of Integrase Inhibitors in routine clinical practice- Kees Brinkman, MD, PhDView Slideset
FZFujie ZhangMD, PhDSlidesetHIVAsia-Pacific HIV Clinical Forum 2018Clinical Case - Emphasis on Integrase Inhibitors challenges in Asian countries- Fujie Zhang, MD, PhDView Slideset
HLHongzhou LuMD, PhDSlidesetHIVAsia-Pacific HIV Clinical Forum 2018Integrase Inhibitors in second line treatment- Hongzhou Lu, MD, PhDView Slideset
